Basal cell carcinoma as a non-melanoma skin cancer

The label describes the cell of origin and separates the condition from melanoma. It does not mean that the lesion can be ignored: basal cell carcinoma can continue growing into nearby skin and structures when untreated.

Basal cell carcinoma often appears as a pearly bump, an open sore that fails to heal, or a scaly patch, though its appearance varies. Melanoma arises from melanocytes and has different pathology, staging and treatment decisions. Neither condition should be identified from colour or photographs alone.

A biopsy tells the clinician which cells are abnormal and may describe the growth pattern and edges. For basal cell carcinoma, treatment planning focuses heavily on complete local removal or control while preserving nearby function and healthy tissue.

Arrange a dermatology visit for a persistent suspicious area. If basal cell carcinoma is confirmed, the clinician considers its location, size, depth, borders, subtype, previous treatment and your general health. Surgical excision or another form of skin cancer surgery may be recommended.

Do not use melanoma treatment information as a substitute for your own plan. Procedures such as sentinel lymph node biopsy and medicines such as immunotherapy relate to selected melanoma situations and are not routine steps for an ordinary basal cell carcinoma.

Book a timely assessment for a sore that repeatedly heals and returns, a shiny or scar-like area, or a lesion that enlarges, crusts or bleeds. Obtain faster care if bleeding persists despite firm pressure, infection signs develop, pain escalates, or a growth near the eye, nose, ear or mouth begins affecting function.

Ask what the biopsy calls the lesion, whether the report describes a higher-risk pattern, which treatment provides appropriate margin control, how the site affects reconstruction and what schedule is advised for checking the remaining skin.